Our strategy
The world’s food systems as business drivers
The global population surpassed 8 billion in 2022 and is projected to reach 9.7 billion
by 2050. Simultaneously, demand for healthier, balanced, and more nutrient-rich diets is rising – driven not only by the growth in the number of people but also by changing public awareness of the connection with health and subsequent consumer expectations.
At the same time, the Intergovernmental Panel on Climate Change (IPCC) Report of 2021 warned that our world is rapidly approaching critical and irreversible tipping points. While food production remains one of the largest contributors to environmental degradation, climate change is already creating considerable challenges worldwide. Multiple systemic and interconnected challenges are impacting the health and well-being of people, animals, and the planet.
Advances in bioscience and digital technology offer realistic scalable solutions to mitigate and even tackle these challenges while creating new markets and innovation opportunities. With our strong combination of scientific competences and our growing portfolio of nutrition and health solutions, we are ideally positioned to capture these opportunities and create value for people and the planet as well as our business.
Our business model for growth
Our Health, Nutrition & Bioscience strategy is derived from our ‘global products, local solutions’ business model and complemented by our growing competences in the rapidly emerging area of ‘precision & personalization’.
We develop global products based on shared scientific foundations, in particular our biotechnology and chemistry expertise, which are then produced at the quality and scale enabled by our internationally diversified manufacturing network. Our growing portfolio includes vitamins, nutritional lipids, carotenoids, minerals, eubiotics, enzymes and yeasts, as well as texturants, flavors and cultures, that have important human and animal nutritional benefits.
Our end-market focus allows us to better understand local needs such that we can deliver relevant solutions for our customers. In turn, this approach opens up additional innovation possibilities. With our significant worldwide premix footprint, together with increasing competences in analytics and diagnostics that enable tailored formulations and delivery systems, we are able to develop customized local solutions for our customers wherever they are.
Through this well-established business model, we have built distinct business groups that benefit from shared capabilities as part of a profitable growth company. Developments in data science and bioscience are creating exciting additional opportunities to address challenges in health and nutrition. Rapid advances in fields such as computational biology, gene technology and Artificial Intelligence (AI) are transforming our ability to better understand and influence the interplay between health, nutrition, and the environment in both human and animal biology, even at an individual level.
We are swiftly developing an additional dimension to our future growth: precision & personalization. Drawing on our emerging capabilities, which were complemented in 2022 by our acquisition of animal nutrition technology company Prodap, we seek to create digital solutions that make the invisible, more visible and deliver unprecedented levels of specificity. Leveraging our reputation, science-based competences, and worldwide customer base, we seek to create digital solutions that deliver more targeted and therefore more effective health solutions as well as measurable sustainability benefits.
